Skyscape Web Viewer : Physicians' Cancer Chemotherapy Drug Manual : Classification Index

View All
Adrenolytic agent
ALK and ROS1 inhibitor
ALK inhibitor Brigatinib Alectinib
Amti HER2 antibody
Anthracycline Daunorubicin Liposome Doxorubicin liposome Idarubicin Daunorubicin Doxorubicin Epirubicin Mitoxantrone
Anthracycline and antimetabolite
Antiandrogen Bicalutamide Flutamide Apalutamide Enzalutamide Nilutamide
Anti angiogenesis agent
Anti angiogenic agent Lenvatinib Thalidomide Lenalidomide Pomalidomide
Antibody drug conjugate Belantamab mafodotin-blmf Enfortumab vedotin-ejfv Inotuzumab ozogamicin Mirvetuximab soravtansine-gynx Tisotumab vedotin-tftv Ado-trastuzumab emtansine Brentuximab Gemtuzumab ozogamicin Loncastuximab tesirine-lpyl Polatuzumab vedotin Trastuzumab deruxtecan
Antibody drug conjugate (ADC)
Anti CD19 monoclonal antibody
Anti CD20 antibody Rituximab Rituximab and human hyaluronidase Tositumomab Ofatumumab Rituximab-abbs Rituximab-pvvr
Anti CD20 monoclonal antibody Mosunetuzumab Ibritumomab Obinutuzumab
Anti CD22 antibody
Anti CD38 directed monoclonal antibody
Anti CD38 monoclonal antibody Daratumumab and Hyaluronidase-fihj Daratumumab
Anti CTLA4 antibody
Adrenal steroid inhibitor
ALK/RON inhibitor
Alkylating agent
Anti CD19 antibody
Anti CD22 immunotoxin
Anti CD52 monoclonal antibody
Anti CTLA4 monoclonal antibody
Anti EGFR MET bispecific monoclonal antibody
Anti EGFR antibody
Anti EGFR monoclonal antibody Cetuximab Necitumumab
Antiestrogen Tamoxifen Toremifene
Antifolate analog